Generation of an induced pluripotent stem cell line AMUFAHi002-A from polycystic ovary syndrome patient
Stem Cell Research, ISSN: 1873-5061, Vol: 63, Page: 102875
2022
- 1Citations
- 8Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations1
- Citation Indexes1
- CrossRef1
- Captures8
- Readers8
Article Description
Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine disorders in women of reproductive age. The PCOS leads to obesity, dyslipidemia, insulin resistance, hyperandrogenism, and infertility. We established an induced pluripotent stem cell line (iPSC) from a PCOS patient. This disease-specific iPSC line will be beneficial to study PCOS in vitro, allowing to understand the pathogenic mechanisms and a cell-based model for drug development for PCOS.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1873506122002240; http://dx.doi.org/10.1016/j.scr.2022.102875; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85135105173&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/35914484; https://linkinghub.elsevier.com/retrieve/pii/S1873506122002240; https://dx.doi.org/10.1016/j.scr.2022.102875
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know